Posttranscriptional regulation of the breast cancer susceptibility gene BRCA1 by the RNA binding protein HuR

Cancer Research

Volumn 68, Issue 22, 2008, Pages 9469-9478

  Saunus, Jodi M ^a   French, Juliet D ^a   Edwards, Stacey L ^a   Beveridge, Dianne J ^c   Hatchell, Esme C ^c   Wagner, Sarah A ^a   Stein, Sandra R ^b   Davidson, Andrew ^d   Simpson, Kaylene J ^e   Francis, Glenn D ^b   Leedman, Peter J ^c   Brown, Melissa A ^a,e  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d ROYAL PERTH HOSPITAL   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; HUR PROTEIN;

3' UNTRANSLATED REGION; ARTICLE; BINDING SITE; BIOINFORMATICS; BREAST CANCER; CANCER SUSCEPTIBILITY; CELL STRAIN MCF 7; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

3' UNTRANSLATED REGIONS; ANTIGENS, SURFACE; BINDING SITES; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION; GENES, BRCA1; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; RNA, MESSENGER; RNA-BINDING PROTEINS;

EID: 56449102504     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-1159     Document Type: Article

References (43)

1. Venkitaraman AR. Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 2002;108:171-82.
2. Vaughn JP, Davis PL, Jarboe MD, et al. BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells. Cell Growth Diff 1996;7:711-15.
3. Saunus JM, Edwards SL, French JD, Smart CE, Brown MA. Regulation of BRCA1 messenger RNA stability in human epithelial cell lines and during cell cycle progression. FEBS Letters 2007;581:3435-42.
4. Wilson CA, Ramos L, Villasenor MR, et al. Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas. Nature Genet 1999;21:236-40.
5. Brown MA, Lo J, Catteau A, et al. Germline BRCA1 promoter deletions in UK and Australian familial breast cancer patients: identification of a novel deletion consistent with BRCA1:yBRCA1 recombination. Human Mutation 2002;19:1-8.
6. Wang A, Schneider-Broussard R, Kumar AP, MacLeod MC, Johnson DG. Regulation of BRCA1 expression by the Rb-E2F pathway. J Biol Chem 2000;275:4532-36.
7. Rice JC, Futscher BW. Transcriptional repression of BRCA1 by aberrant cytosine methylation, histone hypoacetylation and chromatin condensation of the BRCA1 promoter. Nucl Acids Res 2000;28:3233-39.
8. Miyamoto K, Fukotomi T, Asada K, et al. Promoter methylation and post-transcriptional mechanisms for reduced BRCA1 immunoreactivity in sporadic human breast cancers. Japanese J Clin Oncol 2002;32:79-84.
9. Balmer LA, Beveridge DJ, Jazayeri JA, Thomson AM, Walker CE, Leedman PJ. Identification of a novel AU-rich element in the 3′ untranslated region of epidermal growth factor receptor mRNA that is the target for regulated RNA-binding proteins. Mol Cell Biol 2001;21:2070-84.
10. Dean JLE, Wait R, Mahtani KR, Sully G, Clark AR, Saklatvala J. The 3′ untranslated region of tumor necrosis factor α mRNA is the target of the mRNA-stabilizing factor HuR. Mol Cell Biol 2001;21:721-30.
11. Voelkerding KV, Steffen DW, Zaidi SH, Malter JS. Post-transcriptional regulation of the p53 tumor suppressor gene during growth-induction of human peripheral blood mononuclear cells. Oncogene 1995;10:515-21.
12. Giles KM, Daly JM, Beveridge DJ, et al. The 3′-untranslated region of p21WAF1 mRNA is a composite cis-acting sequence bound by RNA-binding proteins from breast cancer cells, including HuR and poly(C)-binding protein. J Biol Chem 2003;278:2937-46.
13. Moore MJ. From birth to death: the complex lives of eukaryotic mRNAs. Science 2005;309:1514-8.
14. Shabalina SA, Ogurtsov AY, Lipman DJ, Kondrashov AS. Patterns in interspecies similarity correlate with nucleotide composition in mammalian 3′UTRs. Nucl Acids Res 2003;31:5433-39.
15. Chen CY, Shyu AB. AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem Sci 1995;20:465-70.
16. Bakheet T, Frevel M, Williams BRG, Greer W, Khabar KSA. ARED: human AU-rich element-containing mRNA database reveals an unexpectedly diverse functional repertoire of encoded proteins. Nucl Acids Res 2001;29:246-54.
17. Kilav R, Silver J, Naveh-Many TA. A conserved cis-acting element in the parathyroid hormone 3′-untranslated region is sufficient for regulation of RNA stability by calcium and phosphate. J. Biol Chem 2001;276:8727-33.
18. Wiklund L, Sokolowski M, Carlsson A, Rush M, Schwartz S. Inhibition of translation by UAUUUAU and UAUUUUUAU motifs of the AU-rich RNA instability element in the HPV-1 late 3′ untranslated region. J Biol Chem 2002;277:40462-71.
19. Shestakova EA, Singer RH, Condeelis J. The physiological significance of β -actin mRNA localization in determining cell polarity and directional motility. Proc Natl Acad Sci U S A 2001;98:7045-50.
20. Mignone F, Gissi C, Liuni S, Pesole G. Untranslated regions of mRNAs. Genome Biol 2002;3:Reviews0004.
21. Sobczak K, Krzyzosiak WJ. Structural determinants of BRCA1 translational regulation. J Biol Chem 2002;277:17349-58.
22. Signori E, Bagni C, Papa S, et al. A somatic mutation in the 5′UTR of BRCA1 gene in sporadic breast cancer causes down-modulation of translation efficiency. Oncogene 2001;20:4596-00.
23. Sengupta S, Jang BC, Wu MT, Paik JH, Furneaux H, Hla T. The RNA-binding protein HuR regulates the expression of cyclooxygenase-2. J Biol Chem 2003;278:25227-33.
24. Mazan-Mamczarz K, Galban S, Lopez de Silanes I, et al. RNA-binding protein HuR enhances p53 translation in response to ultraviolet light irradiation. Proc Natl Acad Sci U S A 2003;100:8354-59.
25. Wang W, Caldwell MC, Lin S, Furneaux H, Gorospe M. HuR regulates cyclin A and cyclin B1 mRNA stability during cell proliferation. EMBO J 2000;19:2340-50.
26. Kullmann M, Gopfert U, Siewe B, Hengst L. ELAV/Hu proteins inhibit p27 translation via an IRES element in the p27 5′UTR. Genes Dev 2002;16:3087-99.
27. Lopez de Silanes I, Zhan M, Lal A, Yang X, Gorospe M. Identification of a target RNA motif for RNA-binding protein HuR. Proc Natl Acad Sci U S A 2004;101:2987-92.
28. Lopez de Silanes I, Fan J, Yang X, et al. Role of the RNA-binding protein HuR in colon carcinogenesis. Oncogene 2003;22:7146-54.
29. Denkert C, Weichert W, Pest S, et al. Overexpression of the embryonic-lethal abnormal vision-like protein HuR in ovarian carcinoma is a prognostic factor and is associated with increased cyclooxygenase 2 expression. Cancer Res 2004;64:189-95.
30. Denkert C, Weichert W, Winzer KJ, et al. Expression of the ELAV-like protein HuR is associated with higher tumor grade and increased cyclooxygenase-2 expression in human breast carcinoma. Clin Cancer Res 2004;10:5580-86.
31. Heinonen M, Bono P, Narko K, et al. Cytoplasmic HuR expression is a prognostic factor in invasive ductal breast carcinoma. Cancer Res 2005;65:2157-61.
32. Erkinheimo TL, Lassus H, Sivula A, et al. Cytoplasmic HuR expression correlates with poor outcome and with cyclooxygenase 2 expression in serous ovarian carcinoma. Cancer Res 2003;63:7591-94.
33. Dixon DA, Tolley ND, King PH, et al. Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells. J Clin Invest 2001;108:1657-65.
34. Heinonen M, Fagerholm R, Aaltonen K, et al. Prognostic role of HuR in hereditary breast cancer. Clin Cancer Res 2007;13:6959-63.
35. Wardrop S, kConFab, Brown MA. Identification of functional regulatory elements in intron 2 of the BRCA1 gene. Genomics 2005;86:316-28.
36. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol 1990;215:403-10.
37. Hofacker IL. Vienna RNA secondary structure server. Nucl Acids Res 2003;31:3429-31.
38. French JD, Dunn J, Smart CE, Manning N, Brown MA. Disruption of BRCA1 function results in telomere lengthening and increased anaphase bridge formation in immortalized cell lines. Genes Chromosomes Cancer 2006;45:277-89.
39. Ostareck-Lederer A, Ostareck DH, Standart N, Thiele BJ. Translation of 15-lipoxygenase mRNA is inhibited by a protein that binds to a repeated sequence in the 3′ untranslated region. EMBO J 1994;13:1476-81.
40. Leandersson K, Riesbeck K, Andersson T. Wnt-5a mRNA translation is suppressed by the Elav-like protein HuR in human breast epithelial cells. Nucl Acids Res 2006;34:3988-99.
41. Dormoy-Raclet V, Ménard I, Clair E, et al. The RNA-binding protein HuR promotes cell migration and cell invasion by stabilizing the β-actin mRNA in a U-rich-element-dependent manner. Mol Cell Biol 2007;27:5365-80.
42. Hosey AM, Gorski JJ, Murray MM, et al. Molecular basis for estrogen receptor α deficiency in BRCA1-linked breast cancer. J Natl Cancer Inst 2007;99:1683-94.
43. Swisher EM, Wataru Sakai W, Beth Y, et al. Secondary BRCA1 mutations in BRCA1-mutated ovarian carcinomas with platinum resistance. Cancer Res 2008;68:2581-86.